Is stem cell therapy for Arterial Hypertension FDA-approved?
No generic regenerative cell or exosome product is FDA-approved to treat arterial hypertension. A research designation, clinic registration or claim of vascular repair is not approval.
How stem cells are studied for Arterial Hypertension
Arterial hypertension is persistently elevated systemic blood pressure with multiple genetic, renal, endocrine, vascular, medicine-related and lifestyle contributors. Cell or exosome research may examine vascular or renal mechanisms, but it has not established a replacement for validated diagnosis, lifestyle measures and antihypertensive medicines.
Am I a candidate? → · Arterial Hypertension: full overview → · Arterial Hypertension cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Arterial Hypertension: cell-therapy evidence and registered trials
- How much does stem cell therapy for Arterial Hypertension cost? (2026)
- Arterial Hypertension stem cell therapy — your questions answered (2026)
- Arterial Hypertension: cell-therapy evidence by therapy class
- MSC vs exosomes for Arterial Hypertension: what the registries show